Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension. (Q38065713)
Jump to navigation
Jump to search
scientific article published on 06 December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension. |
scientific article published on 06 December 2012 |
Statements
Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension (English)
Steven H Abman
John P Kinsella
Usha Krishnan
Thomas Kulik
Mary Mullen
David L Wessel
Ian Adatia
Jeffrey Fineman
Usha Raj
Tilman Humpl
Pediatric Pulmonary Hypertension Network (PPHNet)
6 December 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference